Complete Genomics goes IPO
In a few days, there will be an IPO of a steep startup in the field of mass sequencing of the human genomes Complete Genomics . Who follows modern biotechnology - has the opportunity to invest in this business at the very first stage, before the technology becomes mainstream.
It should be noted that until 2010 the genomes of less than 300 people were completely sequenced throughout the world. Complete Genomics did the same for Q3 2010. By the end of the year, it plans 400 genomes per month. We are talking about complete sequencing , which is different from inaccurate SNP tests . By 2014, they plan to process 1 million genomes and lower prices to less than $ 1,000 per person. And this is just the beginning.
According to experts, in the future, the genomes of several billion people in the developed countries of the world must be deciphered and the manufacture of medicines will begin in fact according to individual formulas.
')
Initially, 6 million shares will be placed at prices ranging from $ 12 to $ 14. On the NASDAQ stock exchange, Complete Genomics has a GNOM ticker.
Of course, from a financial point of view, there is a certain risk that any competitor company will achieve success. Still, many companies are developing similar technologies for mass sequencing of genomes: the British DNA Electronics expects to make a hand-held scanner on a CMOS chip, and Pacific Biosciences (the developer of optical sequencing technologies) has already conducted an IPO in late October. The Chinese are also active , and not only they. Decoding the genome is one of the hottest topics of research everywhere: in Europe and in Asia.
It should be noted that until 2010 the genomes of less than 300 people were completely sequenced throughout the world. Complete Genomics did the same for Q3 2010. By the end of the year, it plans 400 genomes per month. We are talking about complete sequencing , which is different from inaccurate SNP tests . By 2014, they plan to process 1 million genomes and lower prices to less than $ 1,000 per person. And this is just the beginning.
According to experts, in the future, the genomes of several billion people in the developed countries of the world must be deciphered and the manufacture of medicines will begin in fact according to individual formulas.
')
Initially, 6 million shares will be placed at prices ranging from $ 12 to $ 14. On the NASDAQ stock exchange, Complete Genomics has a GNOM ticker.
Of course, from a financial point of view, there is a certain risk that any competitor company will achieve success. Still, many companies are developing similar technologies for mass sequencing of genomes: the British DNA Electronics expects to make a hand-held scanner on a CMOS chip, and Pacific Biosciences (the developer of optical sequencing technologies) has already conducted an IPO in late October. The Chinese are also active , and not only they. Decoding the genome is one of the hottest topics of research everywhere: in Europe and in Asia.
Source: https://habr.com/ru/post/107894/
All Articles